MediciNova Inc (MNOV) Live Share Price, Invest From India

MediciNova Inc Stock Performance

as on April 18, 2026 at 6:55 am IST

Day's Low
Day's High
$1.42
Day's Price Range
$1.47
$1.46
2.74%
Downside
0.68%
Upside
52 Week's Low
52 Week's High
$1.17
52-Week Price Range
$1.96
$1.46
20.00%
Downside
34.25%
Upside

MediciNova Inc share price movements today

Previous Close: $1.44
Open: $1.44
Volume: 178.0K
Day's Low - High: $1.42 - $1.47
52 Week Low - High: $1.17 - $1.96

MediciNova Inc Historical Returns

1 Month Return: -2.04 %
3 Month Return: -10 %
1 Year Return: -0.69 %
3 Year Return: -36 %
5 Year Return: 0 %

MediciNova Inc Stock Fundamentals & Key Indicators

Check MediciNova Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$70.4M

EPS (TTM)

-0.3

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

-0.94

EBITDA

-13.3M

Revenue (TTM)

409.7K

Profit Margin

0.00%

Return On Equity TTM

-25.50%

MediciNova Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of MediciNova Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
MediciNova Inc	BUY	$70.4M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$42.7B	130.51%	136.81	8.45%
Vertex Pharmaceuticals Inc	BUY	$110.8B	98.57%	28.42	32.94%
BeiGene, Ltd.	NA	$36.8B	NA	129.84	5.37%
Regeneron Pharmaceuticals Inc	BUY	$78.9B	48.43%	17.98	31.41%

Stock Returns calculator for MediciNova Inc Stock including INR - Dollar returns

The MediciNova Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

MediciNova Inc investment value today

Current value as on today

₹1,09,390

Returns

₹9,390

(+9.39%)

Returns from MediciNova Inc Stock

₹690 (+0.69%)

Dollar Impact

₹8,700 (+8.7%)

Analyst Recommendation on MediciNova Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for MediciNova Inc. Average target price of $9

MediciNova Inc Share Price Target

Get share price movements and forecasts by analysts on MediciNova Inc.

What analysts predicted

83.78%UPSIDE

Target Price

Current Price

$1.46

Analyzed by

7 Analysts

Target

$9.00

MediciNova Inc target price $9, a slight upside of 83.78% compared to current price of $1.46. According to 7 analysts rating.

MediciNova Inc Stock’s Investor Sentiment and Interest

Search interest for MediciNova Inc Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Time period: March 19, 2026 to April 18, 2026

Change:-50% versus previous 30 day period

MediciNova Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	1	-999	-	-	-	-	-	0	0	0
Gross Profit	1	0	0	0	0	0	0	0	0	0
Operating Income	-1	-2	-3	-3	-3	-3	-3	-3	-3	-3
EBITDA	-1	-2	-3	-3	-3	-3	-3	-3	-3	-2
Interest Expense	-	0	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	0	-2	-2	-2	-2	-2	-2	-3	-3	-2
Income Tax Expense	-1,146	0	0	-	-	0	-	-	-	0
Net Income	0	-2	-2	-2	-2	-2	-2	-3	-3	-2
Net Profit Margin	-72.31%	0.21%	0.00%	0.00%	0.00%	0.00%	0.00%	-2437.75%	-2473.56%	-1846.78%

MediciNova Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	4	4	-	1	-	0
Gross Profit	0	0	0	0	0	4	0	1	0	0
Operating Income	-10	-13	-15	-14	-14	-10	-14	-9	-12	-13
EBITDA	-10	-12	-15	-14	-14	-10	-14	-9	-12	-11
Interest Expense	0	0	-	1	0	0	0	-	-	-
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	-10	-12	-14	-12	-13	-10	-14	-8	-11	-11
Income Tax Expense	0	-1	0	0	0	0	0	0	0	0
Net Income	-10	-11	-14	-12	-13	-10	-14	-8	-11	-11
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-346.35%	-251.00%	0.00%	-857.15%	0.00%	-2928.78%

MediciNova Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-2	-2	-2	-2	-2	-2	-3	-3	-2
Operating Cash Flow	0	-3	-2	-2	-1	-3	-2	-1	-2
Investing Cash Flow	0	-	0	0	0	-	-	0	-
Financing Cash Flow	-	-	-	-	-	-	-	-	0
Change in Cash	0	-3	-2	-2	-1	-3	-2	-1	-1

MediciNova Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-11	-14	-12	-13	-10	-14	-8	-11	-11
Operating Cash Flow	-6	-9	-9	-10	-9	-12	-7	-10	-9
Investing Cash Flow	-84	0	0	0	0	-40	39	0	0
Financing Cash Flow	10	42	10	7	20	0	32,461	-	0
Change in Cash	3	34	1	-3	11	-52	32	-10	-9

Global Institutional Holdings in MediciNova Inc

Funds	Holdings
Bridgeway Capital Management, LLC	0.15%
SBI Securities Co Ltd	0.09%
Two Sigma Investments LLC	0.08%
Geode Capital Management, LLC	1.08%
Vanguard Group Inc	1.43%

See all

Insights on MediciNova Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 38.8% return, outperforming this stock by 39.5%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 21.1% return, outperforming this stock by 57.1%
NEGATIVE IMPACT
Price Dip
In the last 7 days, MNOV stock has moved down by -3.4%

About MediciNova Inc

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute respiratory distress syndrome. The company is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.

Organisation	MediciNova Inc
Headquarters	4275 Executive Square, La Jolla, CA, United States, 92037
Industry	Biotechnology
CEO	Dr. Yuichi Iwaki M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of MediciNova Inc

Name	Title
Dr. Yuichi Iwaki M.D., Ph.D.	Co-Founder, President, CEO & Chairman
Dr. Kazuko Matsuda M.D., M.P.H., Ph.D.	Chief Medical Officer & Director
Dr. David H. Crean M.B.A., Ph.D.	Chief Business Officer
Mr. Jason J. Kruger CPA	CFO & Principal Financial Officer

FAQs

What is MediciNova Inc share price today?

MediciNova Inc share price today is $1.46 as on April 18, 2026 at 1:25 am IST at the close of the market. MediciNova Inc share today touched a day high of $1.47 and a low of $1.42.

What is the 52 week high and 52 week low for MediciNova Inc share?

MediciNova Inc share touched a 52 week high of $1.96 on October 31, 2025 and a 52 week low of $1.17 on October 30, 2025. MediciNova Inc stock price today i.e. April 18, 2026 at 1:25 am IST is closed at $1.46,which is 25.51% down from its 52 week high and 25.00% up from its 52 week low.

What is MediciNova Inc's market capitalisation today?

MediciNova Inc market capitalisation is $0.00T as on April 18, 2026 at 1:25 am IST.

How to invest in MediciNova Inc Stock (MNOV) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for MediciNova Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in MediciNova Inc Shares that will get you 1.0274 shares as per MediciNova Inc share price of $1.46 per share as on April 18, 2026 at 1:25 am IST.

What is the minimum amount required to buy MediciNova Inc Stock (MNOV) from India?

Indian investors can start investing in MediciNova Inc (MNOV) shares with as little as ₹92.768 or $1 (as of April 18, 2026 at 4:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹927.68 in MediciNova Inc stock (as per the Rupee-Dollar exchange rate as on April 18, 2026 at 4:41 am IST). Based on MediciNova Inc share’s latest price of $1.46 as on April 18, 2026 at 1:25 am IST, you will get 6.8493 shares of MediciNova Inc. Learn more about fractional shares .